Concepedia

Aubrey Stoch

AS

Statistics

Publications

10

Citations

707

H-Index

10

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Johnson & Johnson (United States)

KU Leuven

Aubrey Stoch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

2008–2018

10

Publications

10

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +14

Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design

Marc L. Reitman, Xiaoyan Chu, Xiaoxin Cai et al. · Clinical Pharmacology & Therapeutics · 2010 · 157 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with <sup>18</sup>F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles

Talakad G. Lohith, Idriss Bennacef, Rik Vandenberghe et al. · Journal of Nuclear Medicine · 2018 · 114 citations · Full text

Medicine, Neurology, Neuroscience +17

Multiple‐Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid‐1 Receptor Inverse Agonist, in Healthy Male Volunteers

Carol Addy, Paul Rothenberg, Susie Li et al. · The Journal of Clinical Pharmacology · 2008 · 49 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin

Daniel Tatosian, Ying Guo, Andrea Schaeffer et al. · Diabetes Therapy · 2013 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

1–5 of 10